Kiadis Pharma N.V

Short Term Long Term Short Term Comparison Long Term Comparison
  • KDS
  • 1d-2.12%
  • 1w-3.87%
  • 1m-6.92%
  • 1y-69.84%
ATH
  • ATH Price$15.30
  • ATH Date2018-09-14
  • % since ATH-89.44%
  • % to ATH847.37%
ATL
  • ATL Price$1.27
  • ATL Date2020-04-03
  • % from ATL27.17%
  • Last Low Price$1.27
  • Last Low Date2020-04-03
  • % From Last Low27.17%
IPO
  • IPO Price$12.50
  • % Current ROI USD-87.08%
  • ATH Price$15.30
  • % ROI ATH 120,472.44%
[addtoany]

Graph takes few seconds to load...

[financial_chart symbol="KDS"]

Key Data [addtoany]

Current price $1.615
Sector Healthcare
Industry Biotechnology
Today's High/Low $1.649/$1.6
Volume 212,674.00
Previous Close $1.65
52 Week High/Low $5.36/$1.251
Market Cap 48,780,600.00
P/E Ratio 0
Forward P/E 1 Yr. $0.00
Earnings Per Share(EPS) $0
Annualized Dividend $0
$1.615
[addtoany]
Annual Data | Millions of US $ except per share data
Cash on hand
Receivables
Inventory
Pre-Paid Expenses
Other Current Assets
Total Current Assets
Property, Plant, And Equipment
Long-Term Investments
Goodwill And Intangible Assets
Other Long-Term Assets
Total Long-Term Assets
Total Assets
Total Current Liabilities
Long Term Debt
Other Non-Current Liabilities
Total Long Term Liabilities
Total Liabilities
Common Stock Net
Retained Earnings (Accumulated Deficit)
Comprehensive Income
Other Share Holders Equity
Share Holder Equity
Total Liabilities And Share Holders Equity